全文获取类型
收费全文 | 2869篇 |
免费 | 212篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 91篇 |
妇产科学 | 25篇 |
基础医学 | 382篇 |
口腔科学 | 65篇 |
临床医学 | 422篇 |
内科学 | 546篇 |
皮肤病学 | 32篇 |
神经病学 | 201篇 |
特种医学 | 336篇 |
外国民族医学 | 1篇 |
外科学 | 399篇 |
综合类 | 34篇 |
一般理论 | 3篇 |
预防医学 | 154篇 |
眼科学 | 58篇 |
药学 | 143篇 |
中国医学 | 6篇 |
肿瘤学 | 178篇 |
出版年
2021年 | 27篇 |
2020年 | 21篇 |
2019年 | 27篇 |
2018年 | 48篇 |
2017年 | 45篇 |
2016年 | 44篇 |
2015年 | 47篇 |
2014年 | 65篇 |
2013年 | 84篇 |
2012年 | 93篇 |
2011年 | 107篇 |
2010年 | 91篇 |
2009年 | 103篇 |
2008年 | 90篇 |
2007年 | 68篇 |
2006年 | 79篇 |
2005年 | 86篇 |
2004年 | 56篇 |
2003年 | 79篇 |
2002年 | 71篇 |
2001年 | 88篇 |
2000年 | 70篇 |
1999年 | 71篇 |
1998年 | 71篇 |
1997年 | 76篇 |
1996年 | 85篇 |
1995年 | 68篇 |
1994年 | 61篇 |
1993年 | 66篇 |
1992年 | 66篇 |
1991年 | 58篇 |
1990年 | 76篇 |
1989年 | 84篇 |
1988年 | 83篇 |
1987年 | 72篇 |
1986年 | 75篇 |
1985年 | 74篇 |
1984年 | 55篇 |
1983年 | 57篇 |
1982年 | 47篇 |
1981年 | 35篇 |
1980年 | 33篇 |
1979年 | 38篇 |
1978年 | 18篇 |
1977年 | 25篇 |
1976年 | 22篇 |
1975年 | 33篇 |
1974年 | 26篇 |
1973年 | 17篇 |
1971年 | 14篇 |
排序方式: 共有3090条查询结果,搜索用时 15 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
Ophira Salomon Joseph Moisseiev Tamara Vilganski Rima Dardik Shimon Kurtz Eva Shpringer David M Steinberg Nurit Rosenberg 《Blood coagulation & fibrinolysis》2006,17(6):485-488
To determine whether polymorphisms of platelet surface glycoprotein associated with arterial thrombosis are risk factors for branch retinal vein occlusion. A case-control study in which 69 patients with branch retinal vein occlusion and 147 controls who attended the eye clinic for nonvascular complications participated. DNA was extracted from whole blood and analyzed for genotyping of platelet glycoprotein polymorphisms by polymerase chain reactions and specific restricted enzymes. No relationship was found between the four platelet glycoprotein polymorphisms i.e. GPIa C807T, VNTR and Kozak of glycoprotein Ibalpha, the HPA-1 of glycoprotein IIIa and the occurrence of branch retinal vein occlusion. The HPA-2 polymorphism was found in 18 out 60 (30%) patients with branch retinal vein occlusion in comparison with 27 out 142 (19%) of controls, with an estimated odds ratio of 1.8 (95% confidence interval, 0.91-3.65). The four platelet glycoprotein polymorphisms are not risk factors for branch retinal vein occlusion and therefore it seems unnecessary to screen those patients for it. A larger study is required, however, to determine whether HPA-2 is a novel risk factor for branch retinal vein occlusion. 相似文献
3.
Regulation of erythropoietin production 总被引:6,自引:0,他引:6
4.
5.
6.
7.
8.
Lymphangiomatosis is a rare disorder of the lymphatic system that is known to cause chylothorax. Chyloptysis may occur but chylous bronchial cast formation is rare. A case is reported of lymphangiomatosis in a 34 year old woman whose initial manifestation was cough productive of bronchial casts. Two years later the patient developed a chylothorax. Ligation of the thoracic duct through a low thoracotomy was curative. 相似文献
9.
10.